Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -1.68%37.99B | 0.83%23.94B | -0.76%38.64B | -0.53%23.74B | 10.40%38.93B | 13.60%23.87B | 5.62%35.26B | 7.02%21.01B | 6.17%33.39B | 12.79%19.63B |
| Operating income | -1.68%37.99B | 0.83%23.94B | -0.76%38.64B | -0.53%23.74B | 10.40%38.93B | 13.60%23.87B | 5.62%35.26B | 7.02%21.01B | 6.17%33.39B | 12.79%19.63B |
| Cost of sales | 2.41%-21.63B | 2.91%-12.24B | 2.93%-22.16B | 2.14%-12.61B | -5.19%-22.83B | -6.14%-12.88B | -6.84%-21.7B | -7.11%-12.14B | -4.85%-20.31B | -9.16%-11.33B |
| Operating expenses | 2.41%-21.63B | 2.91%-12.24B | 2.93%-22.16B | 2.14%-12.61B | -5.19%-22.83B | -6.14%-12.88B | -6.84%-21.7B | -7.11%-12.14B | -4.85%-20.31B | -9.16%-11.33B |
| Gross profit | -0.70%16.36B | 5.07%11.7B | 2.31%16.48B | 1.35%11.14B | 18.74%16.1B | 23.80%10.99B | 3.72%13.56B | 6.90%8.88B | 8.27%13.07B | 18.14%8.31B |
| Selling expenses | 7.84%-7.72B | 10.74%-3.74B | -3.88%-8.38B | -7.03%-4.19B | -19.48%-8.07B | -21.55%-3.91B | -0.10%-6.75B | 2.16%-3.22B | -10.13%-6.74B | -12.44%-3.29B |
| Administrative expenses | 4.15%-3.17B | -22.03%-1.82B | 1.75%-3.3B | 5.52%-1.49B | -1.27%-3.36B | -17.09%-1.58B | 8.26%-3.32B | 17.78%-1.35B | 18.10%-3.62B | 10.20%-1.64B |
| Special items of operating profit | -143.02%-832M | -0.79%1B | -27.05%1.93B | 5.55%1.01B | 21.44%2.65B | -7.10%955M | -38.39%2.18B | -61.10%1.03B | 110.02%3.54B | 377.08%2.64B |
| Operating profit | -31.02%4.64B | 10.50%7.15B | -8.18%6.73B | 0.20%6.47B | 29.13%7.33B | 20.90%6.46B | -9.29%5.67B | -11.30%5.34B | 94.25%6.26B | 112.42%6.02B |
| Financing cost | 20.21%-75M | 75.00%-14M | 61.48%-94M | 58.52%-56M | -208.86%-244M | -462.50%-135M | -315.79%-79M | 17.24%-24M | 91.00%-19M | -866.67%-29M |
| Share of profits of associates | 4,840.00%741M | 61,200.00%613M | 400.00%15M | 133.33%1M | 92.54%-5M | 92.68%-3M | -219.05%-67M | ---41M | ---21M | ---- |
| Earning before tax | -20.18%5.31B | 20.78%7.75B | -6.06%6.65B | 1.52%6.41B | 28.04%7.08B | 19.77%6.32B | -11.05%5.53B | -11.95%5.28B | 106.55%6.22B | 111.62%5.99B |
| Tax | -12.86%-2.13B | -18.38%-1.99B | -1.39%-1.89B | -3.77%-1.68B | -58.23%-1.86B | -10.05%-1.62B | 27.51%-1.18B | 13.16%-1.47B | -77.60%-1.63B | -126.91%-1.7B |
| After-tax profit from continuing operations | -33.31%3.17B | 21.64%5.76B | -8.73%4.76B | 0.74%4.73B | 19.86%5.21B | 23.53%4.7B | -5.23%4.35B | -11.48%3.8B | 119.20%4.59B | 106.14%4.3B |
| Earning after tax | -33.31%3.17B | 21.64%5.76B | -8.73%4.76B | 0.74%4.73B | 19.86%5.21B | 23.53%4.7B | -5.23%4.35B | -11.48%3.8B | 119.20%4.59B | 106.14%4.3B |
| Minority profit | -1,085.00%-197M | -214.29%-32M | -67.21%20M | -42.86%28M | 916.67%61M | 4,800.00%49M | 100.00%6M | -80.00%1M | --3M | 0.00%5M |
| Profit attributable to shareholders | -28.87%3.37B | 23.04%5.79B | -8.03%4.74B | 1.20%4.71B | 18.62%5.15B | 22.28%4.65B | -5.30%4.34B | -11.40%3.8B | 119.05%4.59B | 106.40%4.29B |
| Basic earnings per share | -28.77%1.04 | 22.76%1.78 | -8.18%1.46 | 1.40%1.45 | 18.66%1.59 | 22.22%1.43 | -4.96%1.34 | -11.36%1.17 | 116.92%1.41 | 106.25%1.32 |
| Diluted earnings per share | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- | Deloitte Touche Tohmatsu Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.